...tiagabine from Cephalon; Lyrica pregabalin from Pfizer; and the generics carbamazepine, clonazepam, clorazepate, divalproex sodium, ethosuximide...

...NASDAQ:CEPH); Lyrica pregabalin from Pfizer Inc. (NYSE:PFE); and the generics carbamazepine, clonazepam, clorazepate, divalproex sodium, ethosuximide...

...from Pfizer; Topamax topiramate from Johnson & Johnson; and the generics carbamazepine; clonazepam; clorazepate; divalproex; ethosuximide...

...Topamax topiramate from Johnson & Johnson (NYSE:JNJ); and the generics carbamazepine; clonazepam; clorazepate; divalproex sodium; ethosuximide...

...COCN had recently lost co-promotion of Parke-Davis' Cognex for Alzheimer's disease, but had acquired Parke-Davis' Zarontin...
...the president of the division, Rick Henson. Watson also will acquire COCN's co-promotion agreements for Zarontin...
...COCN had recently lost co-promotion of Parke-Davis' Cognex for Alzheimer's disease, but had acquired Parke-Davis' Zarontin...

...acquire COCN's co-promotion agreements to market Somerset Pharmaceuticals' Eldepryl selegiline for Parkinson's disease and Parke-Davis' Zarontin...

...COCN will exclusively market Parke-Davis's Zarontin pediatric epilepsy drug to neurologists in the U.S. COCN and...